"GLP-1 receptor agonist use was associated with a higher risk of clinically recorded alopecia, particularly non-scarring alopecia, in patients with type 2 diabetes, compared with SGLT-2 and DPP-4 inhibitors," write the researchers in their published paper
As a physician, what is it like to dedicate so much time to a disease like this
Since Wegovy and Ozempic contain the same active ingredient working through identical mechanisms, they cause the same side effects at similar rates
However, individualization is key
Asthon Collins, director of Save Face, told the Guardian it isn't clear whether these issues were caused by poor technique, counterfeits - there are multiple websites claiming to sell the same product - or the official Lemon Bottle
Where are we today and where have we come from